AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Kgl skin study center3/15/2023 ![]() ![]() acnes reduction assay is a valuable pre-clinical tool in assessing efficacy and tolerability of acne treatments early in commercial development and positive results can serve as a strong surrogate for success in 12-week Phase 3 acne clinical trials. acnes correlates with therapeutic effectiveness. Kligerman, CEO or Kathy Jamison, Manager, Contracts and. ical and physical insult due to increased skin hydration. Historical data has demonstrated that a mean reduction of 1.0 to 2.0 logarithm colony forming units of C. Interstitial Cystitis: Update on Etiologies and Therapeutic Options Erickson, DR J Womans Health Gender Based Med, Vol. a KGLs Skin Study Center, Broomall, Pa., and b Kimberly-Clark Corporation. ![]() A split face design is employed and test product and vehicle control are applied under supervision. EXPERT PRESENTERS: Stuart Lessin, MD, Medical Director, KGL Skin Study Center, Broomall, PA. ![]() Quantitative bacteriologic cultures are obtained from facial skin over two to six weeks from twenty-five healthy volunteers pre-screened for high levels of C. KGL Skin Study Center 9 years Executive Director, CCRC Jan 2022 - Present9 months Newtown Square, PA Managing Director, Clinical Research, CCRC Jan 2014 - Jan 20228 years 1 month Broomall, PA. A simple in-vivo assay can evaluate the effects of topical or systemic agents on C. acnes reduction tracks with clinical efficacy of anti-acne treatments. acnes is involved in the pathogenesis of acne and contributes to its inflammatory characteristics. Cutibacterium acnes (formerly Propionibacterium acnes) is an anaerobic diphther-oid and a native constituent of the skin microbiome. ![]()
0 Comments
Read More
Leave a Reply. |